Country
United States
Moderna Inc said that its candidate vaccine, mRNA-1273, was 94.5% effective in preventing Covid-19 disease in a large Phase 3 study that enrolled more than 30,000 participates in the US.
Full text available to subscribers only. Click here for information on subscribing to MedNous.